Evidence map›Paper›PMID 41715087›Full record

ArticleBMC health services research2026

Service readiness of Public and private health facilities for roll-out of hepatitis C screening and management: a cross-sectional study.

Asma Ummad, Amna Rehana Siddiqui, Aroosa Nighat, Atif Riaz, Hasan Nawaz Tahir, Saeed Hamid, Shehla Zaidi

Abstract read
In one paragraph

Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Asma UmmadThe Aga Khan University, Karachi, Pakistan. asma.ummad@aku.edu.
Amna Rehana SiddiquiAPPNA Institute of Public Health, Jinnah Sindh Medical University, Karachi, Pakistan.
Aroosa NighatAPPNA Institute of Public Health, Jinnah Sindh Medical University, Karachi, Pakistan.
Atif RiazThe Aga Khan University, Karachi, Pakistan.
Hasan Nawaz TahirThe Aga Khan University, Karachi, Pakistan.
Saeed HamidThe Aga Khan University, Karachi, Pakistan.
Shehla ZaidiThe Aga Khan University, Karachi, Pakistan. shehla.zaidi@ucl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDirect-acting antiviral (DAA) therapy has transformed hepatitis C management by enabling cost-effective outpatient treatment. Pakistan, with one of the world’s highest hepatitis C burdens, has set ambitious policy targets for the rollout of DAA therapy supported by rapid screening and confirmatory testing. This study assessed the service readiness of public and private healthcare facilities to inform future scale-up of hepatitis C services in Pakistan.

methodsBetween June 2021 and January 2022, a purposive sample of 39 facilities was selected from 14 high-burden districts in consultation with the National Hepatitis Program: 15 public hospitals, 15 private hospitals, 6 standalone private laboratories, and 3 private blood banks. A cross-sectional descriptive assessment was conducted to evaluate service availability, commodity stocks, staff training, quality-of-care guidelines, reporting mechanisms, supervision, and community engagement. Data were collected through structured questionnaires administered to facility managers and staff, supplemented by an observation checklist.

resultsDAA therapy was available at 10/15 (66.7%) public hospitals and 13/15 (86.7%) private hospitals. HCV screening was offered at 9/15 (60.0%) public hospitals compared to 3/15 (20.0%) private hospitals, with most private hospitals referring patients to standalone laboratories. Case notification was reported by 6/15 (40.0%) public facilities and 4/15 (26.7%) private facilities. In the public sector, DAA stock was available at 7/15 (46.7%) hospitals, but 5/10 (50.0%) of those offering treatment reported recent stock-outs. Private facilities generally prescribed DAAs from external pharmacies. Private laboratories had stronger systems for equipment calibration (4/5, 80.0%) and electronic reporting (5/6, 83.3%), while public facilities were more often supported with standardized guidelines (10/15, 66.7%). Awareness of community referral campaigns remained low in both sectors (≈20–25%).

conclusionThis study found that public facilities were stronger in programmatic guidance, training, and supervision, whereas private facilities demonstrated greater functionality in equipment maintenance and electronic reporting. However, both sectors faced significant gaps: public facilities experienced resource shortages and relied heavily on paper-based systems, while private facilities lacked integration with case notification and standardized guidelines. Scaling up the provision of HCV testing and DAA therapy in Pakistan and similar LMICs requires quality leadership and electronically supported information systems to precede future extensive investment in commodities. Leveraging the comparative strengths of private facilities, services, resources, and online reporting, alongside strengthening public supply chains, will be critical to achieving universal access to hepatitis control services.

Indexed as

Antiviral AgentsHepatitis CHospitals, PublicMass ScreeningPrivate FacilitiesCross-Sectional StudiesHospitals, PrivateHumansPakistanAntiviral AgentsDirect-acting antiviralsHepatitis cPakistanPublic–private mixService readiness

Identifiers

PMID41715087
PMCPMC13032449

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.